Hello readers, please can I ask you for a little time to consider the following…?
eyeforpharma are conducting a ‘state of the industry report’ – to see what the initial impact of COVID-19 has been across pharma (whether you’re in clinical or commercial, China or the UK).
You’ll learn what the key challenges presented have been so far and, most importantly, how pharma are approaching longer term planning as an industry.
The survey only needs 5-10 minutes of your time – and at the end eyeforpharma will produce a 10+ page report with full data sets and analysis, plus some additional case studies.
Don’t worry, its anonymous
Many thanks for reading and for giving a little of your time
FibroFlutters supporting eyeforpharma
FibroFlutters supporting eyeforpharma by Reuters as Patient, Health, Research & Pharma advocates, we are non-commercial.
and if you have a problem we are always open to discussion, just e-mail Carole
PLEASE NOTE: We are not medical professionals, but as patients we are sharing news, articles, information and resources out to you as all stakeholders to help keep you up to date within the Medical healthcare industries and chronic illness health, rare disease and our advocacy work for patients, health, research and pharma, including digital and AI in medicine.
PLEASE NOTE: THAT THIS SITE USES GOOGLE ANALYTICS TO COLLECT DEMOGRAPHIC INFORMATION FOR INFORMATION AND CONTENT DECISION MAKING PURPOSES ONLY AND NOT TO SELL TO 3RD PARTIES.
MANY THANKS in advance for your understanding –
from the administrator – fibrofly73 aka Carole
And my profile on Synapse where you can read about the initiatives that I am involved with
FibroFlutters on Synapse where you can read about the initiatives that we are involved with